Concepedia

Author

Ewa Wunsch

Pomeranian Medical UniversityORCID

Also Known As

E Wunsch, E Wünsch, E. Wunsch, Ewa WUNSCH, Ewa Wunsch, Joanna Raszeja-Wyszomirska, Wunsch, Ewa

106

Publications

1.4K

Citations

23

H-Index

32

Concepts

All Affiliations

Pomeranian Medical UniversityMedical University of WarsawSaarland UniversityUniversité LavalUniversity of Birmingham
EW

About

Ewa Wunsch is an author at Pomeranian Medical University specializing in medicine, hepatology, and liver transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

210

2

Public Health

1

1

23

3

Allergy

1

1

24

4

Cell Biology

1

1

95

5

Epidemiology

1

1

23

Ewa Wunsch

×

38

Publications

1.2K

Citations

23

H-Index

YearCitations

Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis

Ewa Wunsch, Jocelyn Trottier, Małgorzata Milkiewicz,

Hepatology

2014

125

Expression of hepatic Fibroblast Growth Factor 19 is enhanced in Primary Biliary Cirrhosis and correlates with severity of the disease

Ewa Wunsch, Małgorzata Milkiewicz, Urszula Wasik,

Scientific Reports

2015

95

Enhanced liver fibrosis test predicts transplant‐free survival in primary sclerosing cholangitis, a multi‐centre study

Elisabeth M. G. de Vries, Martti Färkkilâ, Piotr Milkiewicz,

Liver International

2017

77

Serum Autotaxin is a Marker of the Severity of Liver Injury and Overall Survival in Patients with Cholestatic Liver Diseases

Ewa Wunsch, Marcin Krawczyk, Małgorzata Milkiewicz,

Scientific Reports

2016

64

Autoimmune hepatitis exerts a profound, negative effect on health‐related quality of life: A prospective, single‐centre study

Maciej K. Janik, Ewa Wunsch, Joanna Raszeja‐Wyszomirska,

Liver International

2018

54

Assessment of health related quality of life in polish patients with primary biliary cirrhosis

Joanna Raszeja‐Wyszomirska, Ewa Wunsch, Marek Krawczyk,

Clinics and Research in Hepatology and Gastroenterology

2015

46

Impact on follow‐up strategies in patients with primary sclerosing cholangitis

Annika Bergquist, Tobias J. Weismüller, Cynthia Levy,

Liver International

2022

39

Prospective evaluation of <scp>PBC</scp>‐specific health‐related quality of life questionnaires in patients with primary sclerosing cholangitis

Joanna Raszeja‐Wyszomirska, Ewa Wunsch, Marek Krawczyk,

Liver International

2014

38

Effect of S-Adenosyl-L-Methionine on Liver Biochemistry and Quality of Life in Patients with Primary Biliary Cholangitis Treated with Ursodeoxycholic Acid. A Prospective, Open Label Pilot Study

Ewa Wunsch, Joanna Raszeja‐Wyszomirska, Olivier Barbier,

Journal of Gastrointestinal and Liver Diseases

2018

38

Anti‐glycoprotein 2 (anti‐GP2) IgA and anti‐neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3‐ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis

Ewa Wunsch, Gary L. Norman, Małgorzata Milkiewicz,

Alimentary Pharmacology & Therapeutics

2020

38

Page 1